TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
Top Cited Papers
- 1 August 2000
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 157 (2) , 377-384
- https://doi.org/10.1016/s0002-9440(10)64550-6
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Activating c-kit Gene Mutations in Human Germ Cell TumorsThe American Journal of Pathology, 1999
- Suppression of src-induced transformed phenotype by expression of tropomyosin-1Oncogene, 1999
- Inflammatory Myofibroblastic Tumor or Inflammatory Fibrosarcoma?Pathology Case Reviews, 1998
- ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)Oncogene, 1997
- Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous systemOncogene, 1997
- A Sequence Analysis of the Genomic Regions Involved in the Rearrangements between TPM3 and NTRK1 Genes Producing TRK Oncogenes in Papillary Thyroid CarcinomasGenomics, 1995
- Expression, Cytoskeletal Utilization and Dimer Formation of Tropomyosin Derived from Retroviral‐Mediated cDNA TransferEuropean Journal of Biochemistry, 1994
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994
- Human fibroblast tropomyosin isoforms: Characterization of cDNA clones and analysis of tropomyosin isoform expression in human tissues and in normal and transformed cellsCell Motility, 1993
- Inflammatory Fibrosarcoma of the Mesentery and RetroperitoneumThe American Journal of Surgical Pathology, 1991